Meredith Fisher
Fondateur chez Violet Therapeutics
Profil
Meredith is a Partner with the Innovation Fund focusing on early stage investments and company creation.
Previously, she was in the private/family office at Bracebridge Capital serving as Director of Private Investments where she led investments in early stage life science companies.
Prior to that role she led business development for Ginkgo BioWorks- an MIT spin out- and was Senior Director of Technology and Business Development of Enlight Biosciences- a venture creation company founded by PureTech Ventures.
She spent several years working as a scientist in drug discovery and assay development for Idenix Pharmaceuticals and Anadys Pharmaceuticals (formerly, Scriptgen).
Meredith received her undergraduate degree from Mount Holyoke College, her MBA from the MIT Sloan School of Management and her PhD from Harvard University.
While at Harvard, she co-founded Harvard Graduate Women in Science and Engineering (HGWISE).
Meredith is a member of the Board of Directors at Metera and she represents the fund on the boards of Nocion and Mediar Therapeutics, and as a board observer at Lyndra and Alizé Pharma.
She is the 2019-2020 co-chair of WEST (Women in the Enterprise of Science and Technology) and serves as an advisor to Takeda HATCH.
Postes actifs de Meredith Fisher
| Sociétés | Poste | Début |
|---|---|---|
Mass General Brigham Ventures LLC
 Mass General Brigham Ventures LLC Investment ManagersFinance Mass General Brigham Ventures LLC (Mass General Brigham Ventures) is a venture capital subsidiary of Partners Research Ventures & Licensing founded in 2005. The firm is headquartered in the Cambridge, Massachusetts. | Private Equity Investor | 01/01/2016 |
Nocion Therapeutics, Inc.
 Nocion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nocion Therapeutics, Inc. is a biopharmaceutical company, which targets neurons mediating cough, itch, pain and inflammation without the addictive properties of opioids. The company was founded by Bruce Bean, Clifford Woolf and Bruce David Levy and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | - |
Firecyte Therapeutics, Inc.
 Firecyte Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Firecyte Therapeutics, Inc. is an emerging biotechnology company based in Cambridge, MA that is focused on developing novel treatment strategies for progressive neurodegenerative diseases of the eye. The company's research is centered around the role of microglia and neuroinflammation in these diseases. The team is led by Jonathan Levenson, the Chief Scientific Officer, who has over 16 years of experience in neuropsychiatry, neurodegeneration, and neuroinflammation. The company was founded by Dong Feng Chen and William E. Yelle, who has been the CEO since incorporation. | Directeur/Membre du Conseil | - |
Violet Therapeutics
 Violet Therapeutics Medical/Nursing ServicesHealth Services Violet Therapeutics is an American healthcare company founded by Meredith Fisher. Meredith Fisher has been the CEO since incorporation. | Fondateur | 01/01/2022 |
Takeda Digital Ventures
 Takeda Digital Ventures Investment ManagersFinance Takeda Digital Ventures (Takeda Digital Ventures) is a venture capital subsidiary of Takeda Pharmaceutical Co., Ltd. founded in 2018. The firm is headquartered in Cambridge, Massachusetts. | Directeur/Membre du Conseil | - |
Anciens postes connus de Meredith Fisher
| Sociétés | Poste | Fin |
|---|---|---|
Mediar Therapeutics, Inc.
 Mediar Therapeutics, Inc. BiotechnologyHealth Technology Mediar Therapeutics, Inc. develops therapeutics to halt, reverse and fibrosis. The company was founded by Paul Yaworsky in 2018 and is headquartered in Cambridge, MA. | Directeur Général | - |
Bracebridge Capital LLC
 Bracebridge Capital LLC Investment ManagersFinance Bracebridge Capital LLC (Bracebridge) is a SEC-registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded in 1994 by Nancy Zimmerman and Gabriel Sunshine. They are owned by Bracebridge Capital II LP. Bracebridge provides investment advisory services to pooled investment vehicles. | Private Equity Investor | 31/12/2015 |
Enlight Biosciences LLC
 Enlight Biosciences LLC Pharmaceuticals: MajorHealth Technology Enlight Biosciences LLC develops research tools for drug discovery and development. It offers patient-centric platforms that may impact all aspects of the connected health ecosystem from patient engagement and experience, to patient-focused research and development. The company was founded by Raju S. Kucherlapati, David Steinberg, Rakesh Kumar Jain, H. Robert Horbitz, and Sanjiv Sam Gambhir in July 2008 and is headquartered in Boston, MA. | Directeur Technique/Scientifique/R&D | 31/12/2012 |
| IDENIX PHARMACEUTICALS INC | Corporate Officer/Principal | 31/12/2002 |
| ░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Meredith Fisher
| Harvard University | Doctorate Degree |
| Massachusetts Institute of Technology | Masters Business Admin |
| Mount Holyoke College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Idenix Pharmaceuticals LLC is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA. | Health Technology |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Health Technology |
Bracebridge Capital LLC
Bracebridge Capital LLC Investment ManagersFinance Bracebridge Capital LLC (Bracebridge) is a SEC-registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded in 1994 by Nancy Zimmerman and Gabriel Sunshine. They are owned by Bracebridge Capital II LP. Bracebridge provides investment advisory services to pooled investment vehicles. | Finance |
Mass General Brigham Ventures LLC
Mass General Brigham Ventures LLC Investment ManagersFinance Mass General Brigham Ventures LLC (Mass General Brigham Ventures) is a venture capital subsidiary of Partners Research Ventures & Licensing founded in 2005. The firm is headquartered in the Cambridge, Massachusetts. | Finance |
Enlight Biosciences LLC
Enlight Biosciences LLC Pharmaceuticals: MajorHealth Technology Enlight Biosciences LLC develops research tools for drug discovery and development. It offers patient-centric platforms that may impact all aspects of the connected health ecosystem from patient engagement and experience, to patient-focused research and development. The company was founded by Raju S. Kucherlapati, David Steinberg, Rakesh Kumar Jain, H. Robert Horbitz, and Sanjiv Sam Gambhir in July 2008 and is headquartered in Boston, MA. | Health Technology |
Mediar Therapeutics, Inc.
Mediar Therapeutics, Inc. BiotechnologyHealth Technology Mediar Therapeutics, Inc. develops therapeutics to halt, reverse and fibrosis. The company was founded by Paul Yaworsky in 2018 and is headquartered in Cambridge, MA. | Health Technology |
Nocion Therapeutics, Inc.
Nocion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nocion Therapeutics, Inc. is a biopharmaceutical company, which targets neurons mediating cough, itch, pain and inflammation without the addictive properties of opioids. The company was founded by Bruce Bean, Clifford Woolf and Bruce David Levy and is headquartered in Cambridge, MA. | Health Technology |
Takeda Digital Ventures
Takeda Digital Ventures Investment ManagersFinance Takeda Digital Ventures (Takeda Digital Ventures) is a venture capital subsidiary of Takeda Pharmaceutical Co., Ltd. founded in 2018. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Firecyte Therapeutics, Inc.
Firecyte Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Firecyte Therapeutics, Inc. is an emerging biotechnology company based in Cambridge, MA that is focused on developing novel treatment strategies for progressive neurodegenerative diseases of the eye. The company's research is centered around the role of microglia and neuroinflammation in these diseases. The team is led by Jonathan Levenson, the Chief Scientific Officer, who has over 16 years of experience in neuropsychiatry, neurodegeneration, and neuroinflammation. The company was founded by Dong Feng Chen and William E. Yelle, who has been the CEO since incorporation. | Commercial Services |
Violet Therapeutics
Violet Therapeutics Medical/Nursing ServicesHealth Services Violet Therapeutics is an American healthcare company founded by Meredith Fisher. Meredith Fisher has been the CEO since incorporation. | Health Services |